BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37635246)

  • 1. Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study.
    Hillman A; Swafford B; Delavenne C; Fieten H; Boerkamp K; Tietje K
    Vet Comp Oncol; 2023 Dec; 21(4):700-708. PubMed ID: 37635246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
    Davies O; Taylor AJ
    Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breed prevalence and sites of haemangioma and haemangiosarcoma in dogs.
    Srebernik N; Appleby EC
    Vet Rec; 1991 Nov; 129(18):408-9. PubMed ID: 1767484
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemangiosarcoma of the interventricular septum in a dog.
    Thompson DJ; Cave NJ; Scrimgeour AB; Thompson KG
    N Z Vet J; 2011 Nov; 59(6):332-6. PubMed ID: 22040341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour suppressor gene p53 mutation in a case of haemangiosarcoma of a dog.
    Mayr B; Zwetkoff S; Schaffner G; Reifinger M
    Acta Vet Hung; 2002; 50(2):157-60. PubMed ID: 12113170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
    Borgatti A; Fieberg A; Winter AL; Stuebner K; Taras E; Todhunter D; Masyr A; Rendhal A; Vallera DA; Koopmeiners JS; Modiano JF
    Vet Comp Oncol; 2020 Dec; 18(4):664-674. PubMed ID: 32187827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent splenic and right atrial mass at presentation in dogs with HSA: a retrospective study.
    Boston SE; Higginson G; Monteith G
    J Am Anim Hosp Assoc; 2011; 47(5):336-41. PubMed ID: 21852509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes.
    Stewart SD; Ehrhart EJ; Davies R; Khanna C
    Vet Comp Oncol; 2020 Dec; 18(4):811-817. PubMed ID: 32458544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
    Bray JP; Orbell G; Cave N; Munday JS
    J Small Anim Pract; 2018 Feb; 59(2):85-91. PubMed ID: 29210452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutering dogs: effects on joint disorders and cancers in golden retrievers.
    Torres de la Riva G; Hart BL; Farver TB; Oberbauer AM; Messam LL; Willits N; Hart LA
    PLoS One; 2013; 8(2):e55937. PubMed ID: 23418479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine Cutaneous Haemangiosarcoma: Biomarkers and Survival.
    Nóbrega DF; Sehaber VF; Madureira R; Bracarense APFRL
    J Comp Pathol; 2019 Jan; 166():87-96. PubMed ID: 30691610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and haematological features of haemangiosarcoma in dogs.
    Ng CY; Mills JN
    Aust Vet J; 1985 Jan; 62(1):1-4. PubMed ID: 4039924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant haemangioendothelioma (angiosarcoma) in the dog.
    Pearson GR; Head KW
    J Small Anim Pract; 1976 Nov; 17(11):737-45. PubMed ID: 1034853
    [No Abstract]   [Full Text] [Related]  

  • 14. Splenic mass diagnosis in dogs undergoing splenectomy according to breed size.
    O'Byrne K; Hosgood G
    Vet Rec; 2019 May; 184(20):620. PubMed ID: 31040215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Big endothelin-1 as a tumour marker for canine haemangiosarcoma.
    Fukumoto S; Miyasho T; Hanazono K; Saida K; Kadosawa T; Iwano H; Uchide T
    Vet J; 2015 Jun; 204(3):269-74. PubMed ID: 25920760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemangiosarcoma associated with leishmaniasis in three dogs.
    Margarito JM; Ginel PJ; Molleda JM; Moreno P; Novales M; López R
    Vet Rec; 1994 Jan; 134(3):66-7. PubMed ID: 8135017
    [No Abstract]   [Full Text] [Related]  

  • 17. A review of pathological diagnoses made from 87 canine splenic biopsies.
    Day MJ; Lucke VM; Pearson H
    J Small Anim Pract; 1995 Oct; 36(10):426-33. PubMed ID: 8583757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vascular endothelial growth factor in dogs with haemangiosarcoma and haematoma.
    Frenz M; Kaup FJ; Neumann S
    Res Vet Sci; 2014 Oct; 97(2):257-62. PubMed ID: 25241388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swiss Canine Cancer Registry 1955-2008: Occurrence of the Most Common Tumour Diagnoses and Influence of Age, Breed, Body Size, Sex and Neutering Status on Tumour Development.
    Grüntzig K; Graf R; Boo G; Guscetti F; Hässig M; Axhausen KW; Fabrikant S; Welle M; Meier D; Folkers G; Pospischil A
    J Comp Pathol; 2016; 155(2-3):156-170. PubMed ID: 27406312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemangiosarcoma with a metastasis of a malignant mixed mammary gland tumour in a dog.
    Hilbe M; Hauser B; Zlinszky K; Ehrensperger F
    J Vet Med A Physiol Pathol Clin Med; 2002 Oct; 49(8):443-4. PubMed ID: 12450195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.